Enbrel News
Most Popular Enbrel Story
Amgen aims for growth in bone drugs, overseas markets
Amgen's ($AMGN) incoming CEO has high hopes for this year. Now COO, Robert Bradway says he's looking for revenue growth in 2012, thanks in part to international expansion. Another driver: Sales of Read more...
Latest Headlines
- January 10, 2012
- December 13, 2011
- November 23, 2011
- November 1, 2011
- October 29, 2009
- August 5, 2009
- September 19, 2008
- September 5, 2008
- July 21, 2008
- July 16, 2008
- June 19, 2008
- June 17, 2008
- June 5, 2008
- May 2, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
